Moderna (MRNA) Capital Leases (2017 - 2026)
Moderna (MRNA) posted quarterly Capital Leases of $6.0 million for Q2 2026, down 81.25% year-over-year from $32.0 million in Q2 2025, and down 53.85% on a QoQ basis from $13.0 million in Q1 2026.
Moderna (MRNA) Capital Leases (2017 - 2026) Analysis & Trends
Moderna has reported Capital Leases for 10 years, with the latest figure at $6.0 million in Q2 2026.
- Capital Leases for Q2 2026 came in at $6.0 million, down 81.25% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.0 million (down 81.25% YoY), and the FY2025 annual result was $20.0 million, down 48.72% from the prior year.
- Capital Leases fell to $6.0 million in Q2 2026, from $13.0 million in the prior quarter.
- Over five years, Capital Leases peaked at $922.0 million in Q3 2022 and troughed at $6.0 million in Q2 2026.
- A 5-year average of $438.4 million and a median of $575.0 million in 2023 frame the typical range for Capital Leases.
- The widest annual swing landed in 2022, when Capital Leases jumped 368.12%; it then slumped 95.84% in 2025.
- A 5-year view of Capital Leases shows it stood at $912.0 million in 2022, then tumbled by 36.95% to $575.0 million in 2023, then tumbled by 93.22% to $39.0 million in 2024, then sank by 48.72% to $20.0 million in 2025, then plunged by 70.0% to $6.0 million in 2026.
- Per Business Quant data, the three most recent Capital Leases figures were $6.0 million in Q2 2026, $13.0 million in Q1 2026, and $20.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 20.00 Mn |
| Sep 30, 2025 | 26.00 Mn |
| Jun 30, 2025 | 32.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 39.00 Mn |
| Sep 30, 2024 | 625.00 Mn |
| Jun 30, 2024 | 576.00 Mn |
| Mar 31, 2024 | 575.00 Mn |
| Dec 31, 2023 | 575.00 Mn |
| Sep 30, 2023 | 575.00 Mn |
| Jun 30, 2023 | 843.00 Mn |
| Mar 31, 2023 | 831.00 Mn |
| Dec 31, 2022 | 912.00 Mn |
| Sep 30, 2022 | 922.00 Mn |
| Jun 30, 2022 | 641.00 Mn |
| Mar 31, 2022 | 646.00 Mn |
| Dec 31, 2021 | 599.00 Mn |
| Sep 30, 2021 | 238.00 Mn |